"septmike09" - "Frankly it gets tiring listening to all those other great deals. Why doesn't Leo step up to the plate and make one?" Because patience is needed (in my opinion) to maximize the return on the deal. Make a deal now before "B" results are realized (probably by years end or 12 mo.) and not get "full monies worth, or wait until the results are in and maximize the returns on the deal when we know what we have (assuming positive). In my opinion you wait until you have results since we have the money available to last another year (and then some). It all boils down to confidence in the drug. If you think you have it you play your cards accordingly. Thus patience is needed. I believe the quantum leap in appreciation is next year since we will have much greater clarity on many fronts.
Not sure the numbers add up. I was under the impression that we were in the clear until mid-2015 with the current trials. Considering the UofB study will not be on our books, and a chance for partnering some indication of B near term, I'm think mid-2015 is too soon for another round of financing, if needed at all by then. The K 1b/2 trial leaves the door open for much faster advancement into later stage trials. Now is the time for steady accumulation as CTIX will go beast mode before too long.
News 
Market Data 
Discover 
AI
